Subsequent Events	3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	11. Subsequent Events On April 3, 2023, the Fund accepted $6,318,345 of additional subscriptions, to purchase $6,318,345 of additional institutional shares, par value $0.001 per share. On April 21, 2023, the number of shares being purchased was fixed when the purchase price of $24.23 per share was determined by the Fund. As a result, the Fund issued 260,765 shares and received $6,318,345 in proceeds. On April 14, 2023, the Fund's Board of Trustees approved the Fund to offer to repurchase up to 5% of its shares outstanding as of March 31, 2023, commencing on April 28, 2023 through May 31, 2023, with a valuation date of June 30, 2023. On April 25, 2023, the Fund declared a regular distribution for its Institutional Shares in an amount of $0.21 per share. The distribution will be payable to shareholders of record at the close of business on April 27, 2023 and will be paid on May 26, 2023. The distribution will be paid in cash or reinvested in Fund shares for shareholders participating in the Fund's distribution reinvestment plan. On April 25, 2023, the Fund's Board of Trustees approved an amendment of the Amended and Restated Fee Waiver and Expense Support and Reimbursement Agreement (the “Waiver Agreement”) between the Fund and the Investment Adviser, dated as of August 29, 2022, pursuant to which the Investment Adviser had agreed to waive its base management fee and incentive fee for the first 12 months following the date of the commencement of the Fund’s operations. The amended Waiver Agreement provides for the extension of the waiver through December 31, 2023.

Subsequent Events

3 Months Ended

Mar. 31, 2023

11. Subsequent Events

On April 3, 2023, the Fund accepted $6,318,345 of additional subscriptions, to purchase $6,318,345 of additional institutional shares, par value $0.001 per share. On April 21, 2023, the number of shares being purchased was fixed when the purchase price of $24.23 per share was determined by the Fund. As a result, the Fund issued 260,765 shares and received $6,318,345 in proceeds.

On April 14, 2023, the Fund's Board of Trustees approved the Fund to offer to repurchase up to 5% of its shares outstanding as of March 31, 2023, commencing on April 28, 2023 through May 31, 2023, with a valuation date of June 30, 2023.

On April 25, 2023, the Fund declared a regular distribution for its Institutional Shares in an amount of $0.21 per share. The distribution will be payable to shareholders of record at the close of business on April 27, 2023 and will be paid on May 26, 2023. The distribution will be paid in cash or reinvested in Fund shares for shareholders participating in the Fund's distribution reinvestment plan.

On April 25, 2023, the Fund's Board of Trustees approved an amendment of the Amended and Restated Fee Waiver and Expense Support and Reimbursement Agreement (the “Waiver Agreement”) between the Fund and the Investment Adviser, dated as of August 29, 2022, pursuant to which the Investment Adviser had agreed to waive its base management fee and incentive fee for the first 12 months following the date of the commencement of the Fund’s operations. The amended Waiver Agreement provides for the extension of the waiver through December 31, 2023.